Evaluation of feasibility and potential impact of a clinical innovative software tool to support pharmacists to prescribe for minor ailments

dc.contributor.authorTasnim, Humayra
dc.date.accessioned2023-09-05T13:09:53Z
dc.date.issued2023-09-05
dc.date.submitted2023-08-03
dc.description.abstractBackground: The role of community pharmacists has shifted from dispensing prescribed medications to providing patient-focused clinical services such as Pharmacists Prescribing for Minor Ailments (PPMA). These services are expected to improve patient care. Pharmacists across provinces have been given some level of prescriptive authority since 2005. The PPMA service was first introduced in Alberta. Currently, nine out ten Canadian provinces have the authority for PPMA service. Ontario recently adopted PPMA, in January 2023. However, there are several barriers such as workload, time constraints and integration to workflow that can hinder pharmacists’ ability to implement PPMA into existing practice. Technological solutions such as computerized decision support system (CDSS) can help pharmacists and facilitate performing PPMA service. PharmAssess Diagnostics developed a CDSS that provides a digital software platform for pharmacists to provide clinical services such as minor ailment prescribing. Although previous research examined the acceptability and impact of CDSS in other professions, there is paucity of research about the feasibility and impact of implementing supporting software tools into the workflow of community pharmacies on adapting PPMA. Objective: The aim of this project is to evaluate the feasibility and potential impact of a clinical innovative software tool to support pharmacists for minor ailment prescribing. Method: This project followed a mixed method design. It included an anonymous online survey and semi-structured interview with community pharmacists/pharmacy student interns to explore their perspectives on the usability, acceptability, potential impact on integration in workflow and overall effect on workload while using the PharmAssess Diagnostics software for PPMA. In Ontario, pharmacists were recruited via the list of pharmacists in the Ontario College of Pharmacist (OCP) who agreed to be contacted for research purposes. Additionally, the co-op supervisors list from the School of Pharmacy University of Waterloo, and clients of the software company were contacted to be recruited. Demographic (age, gender) and professional characteristics (academic qualification, type of community pharmacy, current position in the pharmacy) were collected from participating pharmacists. Then, pharmacists’ perspectives were examined using a survey with Likert’s scale questions and were summarized. Descriptive statistics were used to describe the distribution of the responses. Semi-structured interviews were conducted with pharmacists/student interns who were further interested in providing their detailed perspectives with the use of this software tool in community pharmacy settings. The interviews were analyzed thematically. Then both forms of data were merged using the side-by-side approach to draw conclusion. Results: A total of 11 survey responses were collected. Pharmacists agreed that the software tool was usable (72%), acceptable (81%), had positive impact on workload (63%) and had positive impact on workflow (45%). Overall, 90% of participants stated that the average time per consultation using the software tool ranged between 5 to 15 minutes. Seven pharmacists were interviewed virtually. Three major themes emerged from the interviews, revealing usability of the software tool, facilitators, and barriers to the implementation of the software tool and impact of the software tool implementation into community pharmacy.en
dc.identifier.urihttp://hdl.handle.net/10012/19832
dc.language.isoenen
dc.pendingfalse
dc.publisherUniversity of Waterlooen
dc.subjectthesisen
dc.titleEvaluation of feasibility and potential impact of a clinical innovative software tool to support pharmacists to prescribe for minor ailmentsen
dc.typeMaster Thesisen
uws-etd.degreeMaster of Scienceen
uws-etd.degree.departmentSchool of Pharmacyen
uws-etd.degree.disciplinePharmacyen
uws-etd.degree.grantorUniversity of Waterlooen
uws-etd.embargo2025-09-04T13:09:53Z
uws-etd.embargo.terms2 yearsen
uws.contributor.advisorAlsabbagh, Wasem
uws.contributor.affiliation1Faculty of Scienceen
uws.peerReviewStatusUnrevieweden
uws.published.cityWaterlooen
uws.published.countryCanadaen
uws.published.provinceOntarioen
uws.scholarLevelGraduateen
uws.typeOfResourceTexten

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Tasnim_Humayra.pdf
Size:
2.11 MB
Format:
Adobe Portable Document Format
Description:
thesis

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.4 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections